There are no generic versions of Oracea (doxycycline) licensed for sale at this time. The medication is currently under the protection of a patent that prevents any generic versions from being manufactured. The earliest predictable date that a generic version could become available is August 2016, when the first patent expires.
Oracea® (doxycycline) is a prescription medication approved for treating rosacea. It is the only doxycycline medication approved for this use. It is taken just once a day and provides a low dose of doxycycline (too low to provide significant antibacterial effects but enough to provide anti-inflammatory effects).
This medication is made by Catalent Pharma Solutions, LLC for Galderma Laboratories, L.P. It is currently under the protection of patents that prevent any generic Oracea from being manufactured in the United States.
The first patent for Oracea currently expires in August 2016. This is the earliest predictable date that a generic version of Oracea could become available. However, there are other circumstances that could come up to extend or shorten the exclusivity period of Oracea. This could include such things as lawsuits or other patents for specific Oracea uses.
Once Oracea goes off patent, there may be several companies that will manufacture a generic form of the drug.
The answer is no. Doxycycline is the active ingredient in Oracea (as well as several other medications) but is not a generic version of Oracea. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off patent, and another company besides the original manufacturer must make the product.
There are no other doxycycline products that are equivalent to Oracea.